Wnt pathway markers in molecular subgroups of glioblastoma

Marton Tompa, Adam Nagy, S. Komoly, B. Kálmán

Research output: Contribution to journalArticle

Abstract

Glioblastoma (GBM)is a highly heterogeneous and aggressive brain tumor. Comprehensive genomic and transcriptomic analyses revealed that GBM segregates into three subgroups with characteristic signaling pathways. The Wnt pathway recently received increasing attention with the recognition of its importance in tumor development and recurrence through the promotion of glioma stem cells. As an extension of our previous translational studies, here we tested the possible interactions between key subgroup markers (IDH-1 R132H, EGFRvIII and both cytoplasmic and nuclear loss [c-/n-]of NF-1 expression)and the canonical (Wnt3a and beta-catenin)and non-canonical (Wnt5a and Fzd2)Wnt pathway markers by immunohistochemistry. These analyses revealed increased expression levels of both Wnt pathway markers with significant quantitative differences within, but not among subgroups. Wnt5a and Fzd2 levels were higher than the canonical marker levels in all subgroups. The strongest evidence for correlation between expression levels of the EGFRvIII subgroup marker and the Fzd2 Wnt marker was found, but weaker correlations also could be noted for IDH-1 R132H and NF-1 and some Wnt markers. The correlations detected between markers of the canonical and non-canonical pathways raised the possibility of cross-talk between the two pathways. Analyses of tumors with various NF-1 expression patterns (c+/n-; c-/n+ combined with c+/n+, and c-/n-)revealed that aberrant nuclear accumulation of NF-1 is accompanied by nuclear accumulation of beta-catenin, suggesting that they may act synergistically to define the tumor's biology. Altogether, our study presents expression characteristics of Wnt ligands and receptors, and suggests complex molecular interactions in subgroups of GBM.

Original languageEnglish
Pages (from-to)114-125
Number of pages12
JournalBrain research
Volume1718
DOIs
Publication statusPublished - Sep 1 2019

Fingerprint

Wnt Signaling Pathway
Glioblastoma
beta Catenin
Wnt Receptors
Neoplasms
Brain Neoplasms
Glioma
Stem Cells
Immunohistochemistry
Ligands
Recurrence
epidermal growth factor receptor VIII

Keywords

  • Clinical correlations
  • Glioblastoma
  • Molecular subgroups
  • Wnt pathway

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Wnt pathway markers in molecular subgroups of glioblastoma. / Tompa, Marton; Nagy, Adam; Komoly, S.; Kálmán, B.

In: Brain research, Vol. 1718, 01.09.2019, p. 114-125.

Research output: Contribution to journalArticle

Tompa, Marton ; Nagy, Adam ; Komoly, S. ; Kálmán, B. / Wnt pathway markers in molecular subgroups of glioblastoma. In: Brain research. 2019 ; Vol. 1718. pp. 114-125.
@article{70689fe3734149e99947263748c9e72d,
title = "Wnt pathway markers in molecular subgroups of glioblastoma",
abstract = "Glioblastoma (GBM)is a highly heterogeneous and aggressive brain tumor. Comprehensive genomic and transcriptomic analyses revealed that GBM segregates into three subgroups with characteristic signaling pathways. The Wnt pathway recently received increasing attention with the recognition of its importance in tumor development and recurrence through the promotion of glioma stem cells. As an extension of our previous translational studies, here we tested the possible interactions between key subgroup markers (IDH-1 R132H, EGFRvIII and both cytoplasmic and nuclear loss [c-/n-]of NF-1 expression)and the canonical (Wnt3a and beta-catenin)and non-canonical (Wnt5a and Fzd2)Wnt pathway markers by immunohistochemistry. These analyses revealed increased expression levels of both Wnt pathway markers with significant quantitative differences within, but not among subgroups. Wnt5a and Fzd2 levels were higher than the canonical marker levels in all subgroups. The strongest evidence for correlation between expression levels of the EGFRvIII subgroup marker and the Fzd2 Wnt marker was found, but weaker correlations also could be noted for IDH-1 R132H and NF-1 and some Wnt markers. The correlations detected between markers of the canonical and non-canonical pathways raised the possibility of cross-talk between the two pathways. Analyses of tumors with various NF-1 expression patterns (c+/n-; c-/n+ combined with c+/n+, and c-/n-)revealed that aberrant nuclear accumulation of NF-1 is accompanied by nuclear accumulation of beta-catenin, suggesting that they may act synergistically to define the tumor's biology. Altogether, our study presents expression characteristics of Wnt ligands and receptors, and suggests complex molecular interactions in subgroups of GBM.",
keywords = "Clinical correlations, Glioblastoma, Molecular subgroups, Wnt pathway",
author = "Marton Tompa and Adam Nagy and S. Komoly and B. K{\'a}lm{\'a}n",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.brainres.2019.05.008",
language = "English",
volume = "1718",
pages = "114--125",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Wnt pathway markers in molecular subgroups of glioblastoma

AU - Tompa, Marton

AU - Nagy, Adam

AU - Komoly, S.

AU - Kálmán, B.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Glioblastoma (GBM)is a highly heterogeneous and aggressive brain tumor. Comprehensive genomic and transcriptomic analyses revealed that GBM segregates into three subgroups with characteristic signaling pathways. The Wnt pathway recently received increasing attention with the recognition of its importance in tumor development and recurrence through the promotion of glioma stem cells. As an extension of our previous translational studies, here we tested the possible interactions between key subgroup markers (IDH-1 R132H, EGFRvIII and both cytoplasmic and nuclear loss [c-/n-]of NF-1 expression)and the canonical (Wnt3a and beta-catenin)and non-canonical (Wnt5a and Fzd2)Wnt pathway markers by immunohistochemistry. These analyses revealed increased expression levels of both Wnt pathway markers with significant quantitative differences within, but not among subgroups. Wnt5a and Fzd2 levels were higher than the canonical marker levels in all subgroups. The strongest evidence for correlation between expression levels of the EGFRvIII subgroup marker and the Fzd2 Wnt marker was found, but weaker correlations also could be noted for IDH-1 R132H and NF-1 and some Wnt markers. The correlations detected between markers of the canonical and non-canonical pathways raised the possibility of cross-talk between the two pathways. Analyses of tumors with various NF-1 expression patterns (c+/n-; c-/n+ combined with c+/n+, and c-/n-)revealed that aberrant nuclear accumulation of NF-1 is accompanied by nuclear accumulation of beta-catenin, suggesting that they may act synergistically to define the tumor's biology. Altogether, our study presents expression characteristics of Wnt ligands and receptors, and suggests complex molecular interactions in subgroups of GBM.

AB - Glioblastoma (GBM)is a highly heterogeneous and aggressive brain tumor. Comprehensive genomic and transcriptomic analyses revealed that GBM segregates into three subgroups with characteristic signaling pathways. The Wnt pathway recently received increasing attention with the recognition of its importance in tumor development and recurrence through the promotion of glioma stem cells. As an extension of our previous translational studies, here we tested the possible interactions between key subgroup markers (IDH-1 R132H, EGFRvIII and both cytoplasmic and nuclear loss [c-/n-]of NF-1 expression)and the canonical (Wnt3a and beta-catenin)and non-canonical (Wnt5a and Fzd2)Wnt pathway markers by immunohistochemistry. These analyses revealed increased expression levels of both Wnt pathway markers with significant quantitative differences within, but not among subgroups. Wnt5a and Fzd2 levels were higher than the canonical marker levels in all subgroups. The strongest evidence for correlation between expression levels of the EGFRvIII subgroup marker and the Fzd2 Wnt marker was found, but weaker correlations also could be noted for IDH-1 R132H and NF-1 and some Wnt markers. The correlations detected between markers of the canonical and non-canonical pathways raised the possibility of cross-talk between the two pathways. Analyses of tumors with various NF-1 expression patterns (c+/n-; c-/n+ combined with c+/n+, and c-/n-)revealed that aberrant nuclear accumulation of NF-1 is accompanied by nuclear accumulation of beta-catenin, suggesting that they may act synergistically to define the tumor's biology. Altogether, our study presents expression characteristics of Wnt ligands and receptors, and suggests complex molecular interactions in subgroups of GBM.

KW - Clinical correlations

KW - Glioblastoma

KW - Molecular subgroups

KW - Wnt pathway

UR - http://www.scopus.com/inward/record.url?scp=85065453265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065453265&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2019.05.008

DO - 10.1016/j.brainres.2019.05.008

M3 - Article

C2 - 31075260

AN - SCOPUS:85065453265

VL - 1718

SP - 114

EP - 125

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -